Phase IB/II Study of Second-Line Therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in KRAS Wild-Type Metastatic Colorectal Cancer.
Amanda Townsend , Niall Tebbutt , Christos Karapetis , Pamela Cooper
Clinical Cancer Research 24 ( 16) 3838 -3844
2
2018
Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
Dainik Patel , Amanda R. Townsend , Christos Karapetis , Carol Beeke
Annals of Surgical Oncology 23 ( 11) 3616 -3622
8
2016
Returning to work following curative chemotherapy: a qualitative study of return to work barriers and preferences for intervention
Vikki Knott , Stephanie Zrim , E. Michael Shanahan , Peter Anastassiadis
Supportive Care in Cancer 22 ( 12) 3263 -3273
17
2014
Targeted therapy for esophagogastric cancers: a review.
Christos Karapetis , Khattak , Martin
OncoTargets and Therapy 5 91 -102
2012
Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003
Colin Luke , Grantley Gill , Stephen Birrell , Vlad Humeniuk
Journal of Evaluation in Clinical Practice 13 ( 2) 212 -220
2007
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry
Anas Alawawdeh , Timothy Price , Christos Karapetis , Cynthia Piantadosi
Asia-Pacific Journal of Clinical Oncology 18 ( 4) 428 -433
1
2022
204. THE TUMOUR IMMUNE MICROENVIRONMENT IN OESOPHAGEAL ADENOCARCINOMA HAS PROGNOSTIC SIGNIFICANCE
James Lonie , Sandra Brosda , Lauren Aoude , Vanessa Bonazzi
Diseases of the Esophagus 35 ( Supplement_2) doac051. 204 -doac051. 204
2022
Phase 1 study of Zanidatamab Zovodotin (ZW49): Safety Profile and Recommended Dose (RD) in patients with Human Epidermal Growth Factor 2 (HER2)-positive solid cancers
Do-Youn Oh , Philippe L Bedard , Keun-Wook Lee , Hyo Sook Han
MOLECULAR CANCER THERAPEUTICS 22 ( 12)
1
2023
Abstract B130: Phase 1 study of Zanidatamab Zovodotin (ZW49): Safety Profile and Recommended Dose (RD) in patients with Human Epidermal Growth Factor 2 (HER2)-positive solid cancers
Do-Youn Oh , Philippe L Bedard , Keun-Wook Lee , Hyo Sook Han
NaN ( 12_Supplement) B130 -B130
1
2023
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Shubham Pant , Martin Schuler , Gopa Iyer , Olaf Witt
The Lancet Oncology 24 ( 8) 925 -935
46
2023
Practical considerations for treating patients with cancer in the COVID-19 pandemic
Eva Segelov , Craig Underhill , Hans Prenen , Christos Karapetis
JCO Oncology Practice 16 ( 8) 467 -482
67
2020
Assessment of Myocardial Injury in Patients Treated with Immune Checkpoint Inhibitors: A Prospective Study using Biochemical Markers and Advanced Cardiac Imaging
Briella Klazina Egberts , Rajiv Ananthakrishna , Rebecca Perry , Richard J Woodman
Available at SSRN 4760342
2022
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer
Michael D Green , PA Francis , V Gebski , V Harvey
Annals of Oncology 20 ( 11) 1813 -1817
39
2009
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
Niall C Tebbutt , F Murphy , D Zannino , K Wilson
Annals of Oncology 22 ( 8) 1834 -1838
34
2011
Pancreatic cancer epidemiology and survival in an Australian population
Colin Luke , Timothy Price , Christos Karapetis , Nimit Singhal
Asian Pac J Cancer Prev 10 ( 3) 369 -74
28
2009
Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry
Gonzalo Tapia Rico , Timothy J Price , Christos Karapetis , Cynthia Piantadosi
Cancer Biology & Medicine 14 ( 4) 371 -371
20
2017
Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Patients With Indeterminate Extrahepatic Disease on: 18: FDG-PET Scan Before Liver Resection for Metastatic Colorectal Cancer
Geoffrey Yuet Mun Wong , Rajiv Kumar , Carol Beeke , Shahid Ullah
Annals of Surgery 267 ( 5) 929 -935
6
2018
Patterns of care and outcomes for gastric and gastro‐oesophageal junction cancer in an Australian population
M Nazim Abbas , Tim Bright , Timothy Price , Christos Karapetis
ANZ Journal of Surgery 91 ( 12) 2675 -2682
3
2021
Epidermal growth factor receptor (EGF-R) inhibitors for metastatic colorectal cancer
Rebecca Herbertson , Christos Karapetis , Tim Price , Niall Tebbutt
Cochrane Database of Systematic Reviews ( 2) 1 -8
3
2008
Metastatic colorectal cancer-third line therapy and beyond
Tiffany Foo , Amitesh Roy , Christos Karapetis , Amanda Townsend
Expert Review of Anticancer Therapy 24 ( 5) 219 -227
2024